Company transfers equity stake in a strategic deal for future capital rights, resolving outstanding brand disputes and boosting investor confidence.
The biotech company's shares surged after announcing an ambitious plan for its sublingual drug delivery technology and boosting its 2026 financial outlook.
The non-dilutive capital is aimed at advancing the company's battery manufacturing capabilities and bolstering its position in the U.S. supply chain.
The ongoing government shutdown has postponed the release of key economic data, leaving the Federal Reserve and investors in the dark.
All-stock deal aims to create a diversified semiconductor equipment leader, though Axcelis shares dip on the news.
Autonomous trucking firm's shares rose 2.2% in after-hours trading after the billionaire's fund disclosed a 5.7% passive investment.
The recently-listed Hong Kong construction firm's shares plummeted to all-time lows, triggering multiple volatility halts amid a lack of news.
The battery manufacturer secured a key grant to modernize its production facilities and expand workforce development programs.